Last updated at 08 Mar 2024 12:00 PM
Director
DIN: 00038275
Vijay Kumar Batra is currently associated with 2 companies in various capacities such as Designated Partner and Director. They serve as a Director at MEDXPHARM ENTERPRISES LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00038275.Vijay Kumar Batra has previously been associated with 8 companies in roles such as Additional Director, Director and Managing Director.Vijay Kumar Batra is currently involved in 2 different roles. Their most recent position is with ANUPAM RASAYAN INDIA LIMITED as a Director. The first company Vijay Kumar Batra was appointed to as a director was MEDXPHARM ENTERPRISES LLP. Vijay Kumar Batra is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Vijay Kumar Batra is currently associated with 2 companies in various capacities such as Designated Partner and Director. They serve as a Director at MEDXPHARM ENTERPRISES LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00038275.Vijay Kumar Batra has previously been associated with 8 companies in roles such as Additional Director, Director and Managing Director.Vijay Kumar Batra is currently involved in 2 different roles. Their most recent position is with ANUPAM RASAYAN INDIA LIMITED as a Director. The first company Vijay Kumar Batra was appointed to as a director was MEDXPHARM ENTERPRISES LLP. Vijay Kumar Batra is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (8)
4y 6m 2y 3m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ANUPAM RASAYAN INDIA LIMITED | Director | 09-Nov-2020 |